Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels.


Journal

RNA (New York, N.Y.)
ISSN: 1469-9001
Titre abrégé: RNA
Pays: United States
ID NLM: 9509184

Informations de publication

Date de publication:
02 2021
Historique:
received: 14 05 2020
accepted: 05 11 2020
pubmed: 12 11 2020
medline: 22 4 2021
entrez: 11 11 2020
Statut: ppublish

Résumé

Cold-inducible RNA binding protein (CIRBP) is a stress-responsive protein that promotes cancer development and inflammation. Critical to most CIRBP functions is its capacity to bind and posttranscriptionally modulate mRNA. However, a transcriptome-wide analysis of CIRBP mRNA targets in cancer has not yet been performed. Here, we use an ex vivo breast cancer model to identify CIRBP targets and mechanisms. We find that CIRBP transcript levels correlate with breast cancer subtype and are an indicator of luminal A/B prognosis. Accordingly, overexpression of CIRBP in nontumoral MCF-10A cells promotes cell growth and clonogenicity, while depletion of CIRBP from luminal A MCF-7 cells has opposite effects. We use RNA immunoprecipitation followed by high-throughput sequencing (RIP-seq) to identify a set of 204 high confident CIRBP targets in MCF-7 cells. About 10% of these showed complementary changes after CIRBP manipulation in MCF-10A and MCF-7 cells, and were highly interconnected with known breast cancer genes. To test the potential of CIRBP-mediated regulation of these targets in breast cancer development, we focused on

Identifiants

pubmed: 33172965
pii: rna.076422.120
doi: 10.1261/rna.076422.120
pmc: PMC7812870
doi:

Substances chimiques

CIRBP protein, human 0
CST3 protein, human 0
Cystatin C 0
RNA, Messenger 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-201

Informations de copyright

© 2021 Indacochea et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society.

Références

Science. 2012 Oct 19;338(6105):379-83
pubmed: 22923437
J Biomed Sci. 2017 Aug 29;24(1):63
pubmed: 28851455
Cancer Sci. 2015 Apr;106(4):352-8
pubmed: 25611373
Tumour Biol. 2017 Apr;39(4):1010428317695919
pubmed: 28381187
Oncotarget. 2016 Mar 1;7(9):10578-93
pubmed: 26824423
Br J Cancer. 2004 May 17;90(10):1961-8
pubmed: 15138478
Oncogene. 2002 Dec 12;21(57):8705-12
pubmed: 12483523
Cancer Res. 2014 Nov 1;74(21):6119-28
pubmed: 25187386
Oncotarget. 2017 Apr 24;8(43):73793-73809
pubmed: 29088746
Nucleic Acids Res. 2006 Mar 02;34(4):1224-36
pubmed: 16513844
Nat Rev Mol Cell Biol. 2018 May;19(5):327-341
pubmed: 29339797
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Biochim Biophys Acta. 2015 Jul;1849(7):881-6
pubmed: 25316157
Nat Rev Dis Primers. 2019 Sep 23;5(1):66
pubmed: 31548545
Sci Rep. 2016 Jul 14;6:29822
pubmed: 27412325
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
J Biol Chem. 2010 Mar 19;285(12):8887-93
pubmed: 20103595
J Biol Chem. 2001 Dec 14;276(50):47277-84
pubmed: 11574538
PLoS One. 2010 Nov 15;5(11):e13973
pubmed: 21085595
Front Mol Biosci. 2019 Aug 07;6:65
pubmed: 31440515
Trends Genet. 2013 May;29(5):318-27
pubmed: 23415593
Cancer Lett. 2006 Apr 28;235(2):159-76
pubmed: 15893421
Nucleic Acids Res. 2016 Jan 29;44(2):761-75
pubmed: 26673712
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10885-90
pubmed: 22711815
Biochim Biophys Acta. 2006 Mar;1763(3):290-5
pubmed: 16569452
Cancer Sci. 2016 Mar;107(3):298-306
pubmed: 26757339
Sci Rep. 2013;3:2054
pubmed: 23792593
Wiley Interdiscip Rev RNA. 2018 Mar;9(2):
pubmed: 29322631
Gynecol Oncol. 2004 Mar;92(3):881-6
pubmed: 14984956
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):E1759-E1768
pubmed: 29432179
PLoS One. 2014 Mar 19;9(3):e92444
pubmed: 24647355
Mol Cell Biol. 2009 Apr;29(7):1855-68
pubmed: 19158277
Curr Opin Genet Dev. 2018 Feb;48:112-120
pubmed: 29216518
Nat Med. 2013 Nov;19(11):1489-1495
pubmed: 24097189
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Mol Carcinog. 2010 Feb;49(2):130-40
pubmed: 19777567
Breast Cancer Res. 2005;7(5):R844-53
pubmed: 16168131
Trends Cancer. 2017 Jul;3(7):506-528
pubmed: 28718405
Adv Exp Med Biol. 2014;825:1-55
pubmed: 25201102

Auteurs

Alberto Indacochea (A)

Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.
Biomedical Research in Cancer Stem Cells, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.

Santiago Guerrero (S)

Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.

Macarena Ureña (M)

Biomedical Research in Cancer Stem Cells, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.

Ferrán Araujo (F)

Biomedical Research in Cancer Stem Cells, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.

Olga Coll (O)

Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.

Matilde E LLeonart (ME)

Biomedical Research in Cancer Stem Cells, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.
Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Spain.

Fátima Gebauer (F)

Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.
Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH